As an optometrist and a parent, Dr. Yecheskel is acutely aware of the increase in myopia prevalence in North America.¹ And, it’s difficult to be an eye doctor who doesn't have an answer for parents concerned about their child's rapidly progressing myopia. It can be very frustrating when you try repeatedly to slow progression, but see the patient's prescription continuing to grow.
With her own family history of high myopia, Dr. Yecheskel was vigilant about checking her twin daughters for any signs of blurry vision. When her first born, Daniella, began showing some of the signs of vision problems around the age of 8, Dr. Yecheskel immediately took Daniella into the office for an eye exam.
Luckily, Daniella was diagnosed with myopia just after the release of MiSight® 1 day. Dr. Yecheskel had reviewed the clinical data and felt that the results in slowing the progression of myopia were promising, and knew that it would be a safe treatment option since the soft contact lens was FDA approved* to slow the progression of myopia in children aged 8-12 at the initiation of treatment.†² Wanting to choose a treatment that could provide both clear vision and slow the progression of myopia in age-appropriate children,†² Dr. Yecheskel decided to have her daughter become her very first patient fit for MiSight® 1 day contact lenses.
After two-and-a-half years of wearing MiSight® 1 day to slow the progression of her myopia, Daniella's prescription has remained the same.1±‡ Dr. Yecheskel couldn't be happier knowing that the early intervention and treatment of myopia has helped prevent her daughter from suffering long-term complications like glaucoma, cataracts, retinal detachment and myopic maculopathy.³
As kids grow bigger and bigger, their prescription can get stronger and stronger. But it doesn’t have to. Schedule an eye health exam with a MiSight® certified Eye Care Provider today. misight.com/ec...
Subscribe for more videos from MiSight® 1 day: bit.ly/Subscri...
MiSight® 1 day on Facebook: / misightvision
MiSight® 1 day on Instagram: / misightvision
#MiSight #CooperVision #myopia
Indications and Important Safety Information
Rx only
Results may vary.
ATTENTION: Reference the Patient Information Booklet for a complete listing of Indications and Important Safety Information. *Indication: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. Warnings: Problems with contact lenses could result in serious injury to the eye. Do not expose contact lenses to water while wearing them. Under certain circumstances MiSight® lenses optical design can cause reduced image contrast/ghosting/halo/glare in some patients that may cause difficulties with certain visually demanding tasks. Precautions: Daily wear single use only. Patient should always dispose when lenses are removed. No overnight wear. Patients should exercise extra care if performing potentially hazardous activities. Adverse events: Including but not limited to infection/inflammation/ulceration/abrasion of the cornea, other parts of the eye or eyelids. Some of these adverse reactions can cause permanent or temporary loss of vision. If you notice any of the stated in your child, immediately have your child remove the lenses and contact your eye care professional.
†Compared to a single vision 1 day lens over a 3-year period.
± Children aged 8-12 at the initiation of treatment.
‡ No clinically meaningful change in refractive error -0.25D or less from baseline.
References:
1. Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. doi:10.1016/j.ophtha.2016.01.006
2. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567
3. Tideman JW et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia. JAMA Ophthalmol. 2016;134:1355-1363.]
Негізгі бет Тәжірибелік нұсқаулар және стиль Dr. Hannah's story: treating her 8-year old daughter's myopia with MiSight® 1 day
Пікірлер